Molecular mechanism of androgen receptor mutation in multigenerational mild androgen insensitivity syndrome
Endocrine Connections · 01.01.2025 · 14 (1)
DOI: 10.1530/ec-24-0567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Connections, online erschienen am 18.11.2024. Verfasst von Ravind Pandher und 8 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Androgen insensitivity syndrome (AIS) due to androgen receptor (AR) mutations creates a spectrum of clinical presentations based on residual AR function with the mildest impairment creating mild AIS (MAIS) whose undefined molecular mechanism and subtle clinical features leave it less understood and underdiagnosed.
Design
In silico modeling and in vitro androgen bioassay of the mutated AR are used to identify its structural and physiological mechanism. Clinical features and responses to high-dose testosterone treatment of three cases of MAIS across a six-generation family pedigree are described.
Methods
Structural and dynamic in silico molecular modeling and in vitro yeast-based androgen bioassays of the mutant AR are employed. Three cases of MAIS with consistent (gynecomastia and micropenis) and variable (infertility) clinical features across generations are reported, and the effects of high-dose testosterone treatment are studied.
Results
The missense AR exon 8 mutation (nucleotide aga → gga, p.R872G arginine to glycine), known to cause an increased ligand dissociation rate in mutant AR in binding assays, was analyzed. Modeling shows that the mutation weakens the closure energy of the ‘lid’ of the ligand-binding pocket, allowing easier ligand dissociation from the binding site but with unimpaired in vitro androgen bioactivity. High-dose testosterone treatment for 3 years in one young man caused increased virilization and height growth but was ineffective for treating micropenis. Genetic counseling allowed effective prediction of MAIS risks in progeny for carrier and noncarrier sisters.
Conclusions
The differential diagnosis and clinical management of MAIS is reviewed. The novel molecular mechanism of an AR ligand-binding domain mutation in MAIS may be present in other cases of MAIS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
ORCID-Profile: David E Hibbs, Jonathan J Du, Kristine McGrath, Alison Heather, David J Handelsman
Zitieren
APA
Pandher, R., Chang, R., Chang, Y., Hibbs, D. E., Du, J. J., McGrath, K., Heather, A., Jayadev, V., & Handelsman, D. J. (2025). Molecular mechanism of androgen receptor mutation in multigenerational mild androgen insensitivity syndrome. Endocrine Connections, 14(1). https://doi.org/10.1530/ec-24-0567
Vancouver
Pandher R, Chang R, Chang Y, Hibbs DE, Du JJ, McGrath K, et al. Molecular mechanism of androgen receptor mutation in multigenerational mild androgen insensitivity syndrome. Endocrine Connections. 2025;14(1). doi:10.1530/ec-24-0567
BibTeX
@article{Pandher2025,
author = {Pandher, Ravind and Chang, Ruby and Chang, Yiqun and Hibbs, David E and Du, Jonathan J and McGrath, Kristine and Heather, Alison and Jayadev, Veena and Handelsman, David J},
title = {Molecular mechanism of androgen receptor mutation in multigenerational mild androgen insensitivity syndrome},
journal = {Endocrine Connections},
year = {2025},
volume = {14},
number = {1},
doi = {10.1530/ec-24-0567}
}
EUVIMED